The CF salt controversy: in vivo observations and therapeutic approaches. (Q43711753)

26 November 2017

The CF salt controversy: in vivo observations and therapeutic approaches. (English)

1 reference

26 November 2017

Tarran R

1

1 reference

26 November 2017

Grubb BR

2

1 reference

26 November 2017

Parsons D

3

1 reference

26 November 2017

Picher M

4

1 reference

26 November 2017

Hirsh AJ

5

1 reference

26 November 2017

Davis CW

6

1 reference

26 November 2017

Boucher RC

7

1 reference

26 November 2017

1 July 2001

1 reference

26 November 2017

1 reference

26 November 2017

8

1 reference

26 November 2017

149-158

1 reference

26 November 2017

1

1 reference

Human airway ion transport. Part one.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Human airway ion transport. Part two.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Molecular insights into the physiology of the 'thin film' of airway surface liquid

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

UTP inhibits Na+ absorption in wild-type and DeltaF508 CFTR-expressing human bronchial epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Application of microdialysis in pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Pathophysiology of gene-targeted mouse models for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Cystic fibrosis and the salt controversy

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Elemental content of airway surface liquid from infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Na+ and Cl? conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Osmotic water permeabilities of cultured, well-differentiated normal and cystic fibrosis airway epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Coordinated clearance of periciliary liquid and mucus from airway surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Airway goblet cells: responsive and adaptable front-line defenders

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

CFTR as a cAMP-dependent regulator of sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Activation of an apical Cl- conductance by Ca2+ ionophores in cystic fibrosis airway epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

The genesis of cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900286-6

7 January 2021

10.1016/S1097-2765(01)00286-6

Identifiers

DOI

1 reference

26 November 2017

1 reference